LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析

◆英語タイトル:LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME2467990FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

LivaNova PLC (LIVN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, Greater London, the UK.

LivaNova PLC Key Recent Developments

Apr 28,2021: LivaNova Reports First Quarter 2021 Results
Mar 25,2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24,2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05,2021: Medistim partners with LivaNova as their new distributor for India
Dec 07,2020: LivaNova announces board appointment and board leadership changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
LivaNova PLC – Key Facts
LivaNova PLC – Key Employees
LivaNova PLC – Key Employee Biographies
LivaNova PLC – Major Products and Services
LivaNova PLC – History
LivaNova PLC – Company Statement
LivaNova PLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
LivaNova PLC – Business Description
Business Segment: Cardiovascular
Overview
Performance
Business Segment: Neuromodulation
Overview
Performance
Business Segment: Other
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
R&D Overview
LivaNova PLC – Corporate Strategy
LivaNova PLC – SWOT Analysis
SWOT Analysis – Overview
LivaNova PLC – Strengths
LivaNova PLC – Weaknesses
LivaNova PLC – Opportunities
LivaNova PLC – Threats
LivaNova PLC – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2021: LivaNova Reports First Quarter 2021 Results
Mar 25, 2021: LivaNova to Host Conference Call for First Quarter 2021 Results
Feb 24, 2021: LivaNova reports fourth quarter and full-year 2020 results
Jan 05, 2021: Medistim partners with LivaNova as their new distributor for India
Dec 07, 2020: LivaNova announces board appointment and board leadership changes
Dec 04, 2020: LivaNova to host satellite symposium on advances in Neuromodulation at American Epilepsy Society AES2020 virtual event
Oct 29, 2020: LivaNova reports third quarter 2020 results
Jul 29, 2020: LivaNova reports second quarter 2020 results
Jun 29, 2020: LivaNova to Host Conference Call for Second Quarter 2020 Results
Apr 29, 2020: LivaNova reports first quarter 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
LivaNova PLC, Key Facts
LivaNova PLC, Key Employees
LivaNova PLC, Key Employee Biographies
LivaNova PLC, Major Products and Services
LivaNova PLC, History
LivaNova PLC, Subsidiaries
LivaNova PLC, Key Competitors
LivaNova PLC, Ratios based on current share price
LivaNova PLC, Annual Ratios
LivaNova PLC, Annual Ratios (Cont...1)
LivaNova PLC, Annual Ratios (Cont...2)
LivaNova PLC, Interim Ratios
LivaNova PLC, Medical Equipment, Deals By Year, 2015 to YTD 2021
LivaNova PLC, Medical Equipment, Deals By Type, 2015 to YTD 2021
LivaNova PLC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hong Leong Asia Ltd (H22):企業の財務・戦略的SWOT分析
    Hong Leong Asia Ltd (H22) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • St. Barbara Limited:企業の戦略・SWOT・財務情報
    St. Barbara Limited - Strategy, SWOT and Corporate Finance Report Summary St. Barbara Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • Ricerca Biosciences LLC-製薬・医療分野:企業M&A・提携分析
    Summary Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Main Market Partners LLC, is a contract research organization that offers services to accelerate drug development. The organization's service portfolio includes drug safety and metabolism, chemical development, agrochem …
  • Community Health Systems Inc (CYH):製薬・医療:M&Aディール及び事業提携情報
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • Century Casinos Inc:戦略・SWOT・企業財務分析
    Century Casinos Inc - Strategy, SWOT and Corporate Finance Report Summary Century Casinos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mineral Resources Ltd:企業の戦略・SWOT・財務分析
    Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Mineral Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Novartis AG (NOVN):企業の財務・戦略的SWOT分析
    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Caleres Inc (CAL):企業の財務・戦略的SWOT分析
    Caleres Inc (CAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gol Linhas Aereas Inteligentes SA :企業の戦略・SWOT・財務情報
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kansai Paint Co Ltd (4613):企業の財務・戦略的SWOT分析
    Kansai Paint Co Ltd (4613) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Risk Strategies Company Inc:企業のM&A・事業提携・投資動向
    Risk Strategies Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Risk Strategies Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Australian Pharmaceutical Industries Ltd (API):企業の財務・戦略的SWOT分析
    Australian Pharmaceutical Industries Ltd (API) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • New Silkroad Culturaltainment Limited.:戦略・SWOT・企業財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Medusa Mining Ltd:企業の戦略・SWOT・財務分析
    Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Medusa Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Merus Labs International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • EWA Government Systems, Inc.:企業の戦略・SWOT・財務情報
    EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary EWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Genomic Vision SA (GV):企業の財務・戦略的SWOT分析
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Business Development Bank of Canada:企業のM&A・事業提携・投資動向
    Business Development Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Business Development Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆